FDA Brief

Warning letters Food

FDA warning letter to

MKS Enterprise, LLC

High riskIssued Jul 1, 2022Posted Jul 12, 2022Center for Food Safety and Applied Nutrition (CFSAN)

FDA found undeclared tadalafil, the active ingredient in Cialis, in MKS Enterprise's Vital Honey and cited unapproved drug claims.

What happened

FDA bought a sample of Dose Vital Royal Honey VIP Honey from the company's website and reviewed the website in June 2022. Laboratory testing found undeclared tadalafil, the active ingredient in the prescription erectile dysfunction drug Cialis. The website also claimed the honey could prevent or treat arthritis, multiple sclerosis, heart ailments, liver disease, and other conditions.

What FDA found

  1. The honey contains undeclared tadalafil, an approved prescription drug, so it is a food with an added drug and cannot be introduced into interstate commerce.

    FD&C Act section 301(ll) [21 U.S.C. 331(ll)]
  2. Website claims that the honey treats diseases make it a new drug, but FDA has not approved it for those uses.

    FD&C Act sections 201(p), 301(d), and 505(a) [21 U.S.C. 321(p), 331(d), 355(a)]
  3. The product is misbranded because it lacks adequate directions for a layperson to use it safely for its claimed purposes.

    FD&C Act sections 502(f)(1) and 301(a) [21 U.S.C. 352(f)(1), 331(a)]

What FDA wants

FDA tells the company to notify it in writing within 15 working days of the steps taken to correct the violations and prevent recurrence, with supporting documents, or explain why it cannot complete them and when it will.

Who should pay attention

  • retailers and online marketplaces selling honey supplements
  • brands that buy or distribute Vital Honey
  • consumers taking nitrates or heart medications

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  2. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk